These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 19210526

  • 1. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression.
    Toniutto P, Minisini R, Fabris C, De Feo T, Marangoni F, Burlone M, Avellini C, Bitetto D, Fornasiere E, Fumolo E, Baccarani U, Pirisi M.
    Clin Transplant; 2009; 23(2):184-90. PubMed ID: 19210526
    [Abstract] [Full Text] [Related]

  • 2. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [Abstract] [Full Text] [Related]

  • 3. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [Abstract] [Full Text] [Related]

  • 4. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V, Marzano A, Zamboni F, Barbui A, Franchello A, Gaia S, Marchiaro G, Salizzoni M, Rizzetto M.
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [Abstract] [Full Text] [Related]

  • 5. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [Abstract] [Full Text] [Related]

  • 6. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 7. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L, Vargas V, Rodríguez F, Allende H, Buti M, Sánchez-Avila JF, Jardí R, Margarit C, Pumarola T, Esteban R, Guardia J.
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [Abstract] [Full Text] [Related]

  • 8. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
    Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH.
    Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
    [Abstract] [Full Text] [Related]

  • 9. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation.
    Segovia R, Sánchez-Fueyo A, Rimola A, Grande L, Bruguera M, Costa J, Soguero C, Uriz J.
    Liver Transpl; 2001 Feb; 7(2):106-12. PubMed ID: 11172393
    [Abstract] [Full Text] [Related]

  • 10. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.
    Transplantation; 2007 Aug 15; 84(3):331-9. PubMed ID: 17700157
    [Abstract] [Full Text] [Related]

  • 11. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.
    Liver Transpl; 2007 May 15; 13(5):733-40. PubMed ID: 17370330
    [Abstract] [Full Text] [Related]

  • 12. De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: analysis by determining complete sequence of the genome.
    Rokuhara A, Tanaka E, Yagi S, Mizokami M, Hashikura Y, Kawasaki S, Kiyosawa K.
    J Med Virol; 2000 Dec 15; 62(4):471-8. PubMed ID: 11074476
    [Abstract] [Full Text] [Related]

  • 13. Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis.
    Cheung CK, Lo CM, Man K, Lau GK.
    Liver Transpl; 2010 Nov 15; 16(11):1314-23. PubMed ID: 21031547
    [Abstract] [Full Text] [Related]

  • 14. Safe use of livers from donors with positive hepatitis B core antibody.
    Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ.
    Liver Transpl; 2002 Jun 15; 8(6):556-61. PubMed ID: 12037788
    [Abstract] [Full Text] [Related]

  • 15. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
    Torre F, Wong PY, Macartney M, Williams R, Naoumov NV.
    J Med Virol; 1999 Sep 15; 59(1):5-13. PubMed ID: 10440801
    [Abstract] [Full Text] [Related]

  • 16. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.
    Liver Transpl; 2001 Jun 15; 7(6):513-7. PubMed ID: 11443579
    [Abstract] [Full Text] [Related]

  • 17. Dual hepatitis virus infections in liver transplant: case report and a review of the literature.
    Yataco ML, Dickson RC, Bonatti H, Aranda-Michel J, Mendez J, Ghabril M, Nguyen J.
    Clin Transplant; 2009 Jun 15; 23(2):282-8. PubMed ID: 19191801
    [Abstract] [Full Text] [Related]

  • 18. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G.
    N Engl J Med; 1999 Jul 01; 341(1):22-6. PubMed ID: 10387938
    [Abstract] [Full Text] [Related]

  • 19. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan 01; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 20. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL.
    Hepatology; 1997 Dec 01; 26(6):1646-52. PubMed ID: 9398011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.